Condition
Ovarian Aging
Total Trials
6
Recruiting
4
Active
4
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Early P 1 (2)
P 3 (1)
Trial Status
Recruiting4
Suspended1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06831019RecruitingPrimary
The ROAR Study: Reactive Oxygen Species and Reproduction
NCT07214246RecruitingPrimary
Follicular Fluid microRNAs in Ovarian Aging and Reproduction
NCT06609421Suspended
Egg Quality Assessment
NCT06271928Early Phase 1RecruitingPrimary
A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging
NCT06256783Early Phase 1RecruitingPrimary
A Clinical Study of Baozhu Keli in the Treatment of Ovarian Aging
NCT01572025Phase 3Completed
Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging
Showing all 6 trials